Leuprolide Acetate

Spezifikationen

74381-53-6CAS-Nummer

686-285-8EG-Nummer

acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxypheIUPAC-Name

C61H88N16O14Chemische Formel

1269.4 g/molMolekulargewicht

Leuprolide acetate; Leuprorelin acetate; 74381-53-6; Lupron; Lucrin; Carcinil; Enantone; Leuplin; Trenantone; Eligard; Prostap; Viadur; Lupron Depot; Abbott-43818; Fensolvi; Lupaneta; Procrin; TAP-144; Lutrate depot; Uno-Enantone; Leuporelin acetate; TAP-144-SR; Leuprolide Monoacetate; Enanton; Lutrate; Leuprolide acetate depot; LUPRON DEPOT-PED; DTXSID7049009; Abbott 43818; 37JNS02E7V; A-43818; DTXCID2028935; CHEBI:63597; Lupron Depot Ped; Ginecrin; Procren; Depo-Eligard; Enantone-Gyn; Fensolvi Kit; Lucrin Depot; Acetate, Leuprolide; Lupron Depot-Ped Kit; ELIGARD KIT; Lupron Depot-3 Month; Lupron Depot-4 Month; Monoacetate, Leuprolide; NSC377526; RefChem:55466; LUTRATE DEPOT KIT; TAP144; TAP 144; A43818; A 43818; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide monoacetate; 6-D-Leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Pig) Monoacetate; 6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) Monoacetate; 686-285-8; Leuprolide (Acetate); MFCD00072080; 88793-81-1; Leuprolide acetate [USAN]; Leuprin; Leuplin depot; Procren Depot; Depo-Lupron; Lupron PED; LEUPRORELIN ACETATE [JAN]; LUPRON DEPOT-3; LUPRON DEPOT-4; UNII-37JNS02E7V; Onectyl; Leuprolidine;; Carcinil;; Enantone;; Ginecrin;; C61H88N16O14; Enanton;; Leuplin;; Leupron;; Procren;; Prostap;; Leuprolide acetate [USAN:USP]; Lucrin;; Leuprolide Acetate?; Leuprorelin acetate salt; NCGC00183364-01; SCHEMBL3174; MLS000028695; orb315408; orb1089659; SCHEMBL1654929; CHEMBL1200775; SCHEMBL29359846; SCHEMBL29394673; LEUPROLIDE ACETATE [VANDF]; LEUPROLIDE MONOACETATE [MI]; LEUPROLIDE ACETATE [USP-RS]; LEUPRORELIN ACETATE [MART.]; Tox21_113507; LEUPRORELIN ACETATE [WHO-DD]; s3718; AKOS015895632; AKOS030485977; CCG-270666; CS-1434; EBC-153052; FL24877; LEUPROLIDE ACETATE [ORANGE BOOK]; Leuprolide Acetate (Leuprorelin Acetate); 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tryosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide monoacetate (salt); AC-28731; HY-13665; LEUPROLIDE ACETATE [USP MONOGRAPH]; SMR000058945; SY225936; CAS-74381-53-6; L0249; L1881; (Des-Gly10,D-Leu6,Pro-NHEt9)-LHRH acetate; an-22-oyl)-N-ethylpyrrolidine-2-carboxamide acetate; Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt.HOAc; Q27104908; )-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocos; PGLU-HIS-TRP-SER-TYR-D-LEU-LEU-ARG-PRO-NHC2H5 ACETATE SALT; (S)-1-((3S,6S,9S,12S,15R,18S,21S)-3-((1H-imidazol-4-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-15,18-diisobutyl-1,4,7,10,13,16,19-heptaoxo-1-((S; (S)-1-((3S,6S,9S,12S,15R,18S,21S)-3-((1H-imidazol-4-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-15,18-diisobutyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocos; 5-OXO-L-PROLYL-L-HISTIDYL-L-TRYPTOPHYL-L-SERYL-L-TRYOSYL-D-LEUCYL-L-LEUCYL-L-ARGINYL-N-ETHYL-L-PROLINAMIDE ACETATE (SALT); 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tryosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide monoacetate; 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide--acetic acid (1/1); 6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamideluteinizing hormone-releasing factor acetate; Acetic acid--5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide (1/1); L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-, acetate (1:1)Synonyme